None

UCB’s Neupro now available in U.S. pharmacies

UCB announced today that Neupro (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro was approved by the U.S Food and Drug Administration in April to treat the signs and symptom...

UCB's Neupro re-launched in USA for Parkinson's and RSL

Belgium drugmaker UCB (Euronext Brussels: UCB) said yesterday that its Neupro (rotigotine transdermal system) is now available in US pharmacies. Neupro was approved by the US Food and Drug Administrat...

UCB unveils Neupro drug in US market

UCB has launched Neupro (Rotigotine Transdermal System) in US pharmacies for the treatment of Parkinson's disease (PD) and Restless Legs Syndrome (RLS).

UCB Launches Neupro in the U.S. to Treat Parkinson’s Disease and Restless Legs Syndrome

UCB announced today that Neupro® (Rotigotine Transdermal System) is now available in U.S. pharmacies. Neupro® was approved by the U.S. Food and Drug Administration in April to treat the sign...

Neupro Shows Promise For Restless Legs Syndrome Patients

At the 16th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland, German researchers presented results from a clinical analysis of Neupro® (rotigotine transdermal p...

UCB's Neupro hits US market again

UCB has again launched its once daily rotigotine patch Neupro in the US for patients with the signs and symptoms of idiopathic Parkinson's disease and moderate to severe primary Restless Legs Syndrome...

UCB Launches Neupro in the U.S. to Treat Parkinson's Disease and Restless Legs Syndrome

Neupro® (Rotigotine Transdermal System) is now available in U.S. retail pharmacies Neupro® provided significant symptom improvement in patients with Parkinson's disease (PD) and Restless Legs...

UCB relaunches Neupro in the USA

UCB relaunches Neupro in the USA

Synthesis of Robalzotan, Ebalzotan, and Rotigotine Precursors via the Stereoselective Multienzymatic Cascade Reduction of α,β-Unsaturated Aldehydes.

A stereoselective synthesis of bicyclic primary or secondary amines, based on tetralin or chroman structural moieties, is reported. These amines are precursors of important active pharmaceutical ingre...